Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
176
CALL
Accenture
ACN
$107B
| $295M | 0.08% |
1,064,100
+339,200
| +47% | +$102M |
|
177
CALL
Verizon
VZ
$194B
| $295M | 0.08% |
5,807,000
+1,443,700
| +33% | +$73M |
|
178
Goldman Sachs
GS
$306B
| $293M | 0.08% |
986,428
+657,514
| +200% | +$205M |
|
|
179
CALL
lululemon athletica
LULU
$14B
| $290M | 0.07% |
1,065,600
+398,900
| +60% | +$128M |
|
180
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.5B
| $290M | 0.07% |
4,214,600
+612,800
| +17% | +$48.3M |
|
181
CALL
VanEck Semiconductor ETF
SMH
$72.5B
| $289M | 0.07% |
2,839,600
-465,400
| -14% | -$54M |
|
182
PUT
Coca-Cola
KO
$370B
| $289M | 0.07% |
4,591,000
+781,200
| +21% | +$49.5M |
|
183
CALL
Cigna
CI
$72.5B
| $285M | 0.07% |
1,080,900
+231,300
| +27% | +$59.6M |
|
184
CALL
Micron Technology
MU
$1.04T
| $285M | 0.07% |
5,149,700
-234,500
| -4% | -$15.9M |
|
185
CALL
Zscaler
ZS
$28.3B
| $281M | 0.07% |
1,881,800
+165,700
| +10% | +$29.3M |
|
186
CALL
Lam Research
LRCX
$408B
| $281M | 0.07% |
6,584,000
+961,000
| +17% | +$45.7M |
|
187
CALL
Baidu
BIDU
$35.4B
| $277M | 0.07% |
1,865,300
-44,500
| -2% | -$5.88M |
|
188
PUT
General Motors
GM
$77.3B
| $277M | 0.07% |
8,717,100
+163,700
| +2% | +$6.14M |
|
|
189
PUT
Eli Lilly
LLY
$1.08T
| $276M | 0.07% |
852,700
-84,800
| -9% | -$25.5M |
|
190
CALL
Caterpillar
CAT
$397B
| $276M | 0.07% |
1,545,600
-38,100
| -2% | -$8.03M |
|
191
PUT
Morgan Stanley
MS
$343B
| $273M | 0.07% |
3,594,600
-423,700
| -11% | -$34.7M |
|
192
CALL
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $273M | 0.07% |
6,799,500
+626,500
| +10% | +$26.3M |
|
193
PUT
Target
TGT
$69B
| $273M | 0.07% |
1,929,600
+852,700
| +79% | +$163M |
|
194
CALL
Merck
MRK
$324B
| $271M | 0.07% |
2,969,500
-656,900
| -18% | -$58.2M |
|
195
PUT
Ulta Beauty
ULTA
$23B
| $270M | 0.07% |
700,000
+419,000
| +149% | +$167M |
|
|
196
ResMed
RMD
$32.1B
| $268M | 0.07% |
+1,280,595
| New | +$273M |
|
197
CALL
Intuitive Surgical
ISRG
$141B
| $267M | 0.07% |
1,328,300
+451,100
| +51% | +$106M |
|
198
CALL
Elevance Health
ELV
$85.1B
| $265M | 0.07% |
548,200
+333,200
| +155% | +$165M |
|
199
PUT
iShares MSCI Brazil ETF
EWZ
$8.59B
| $264M | 0.07% |
9,652,700
+3,944,200
| +69% | +$131M |
|
|
200
lululemon athletica
LULU
$14B
| $264M | 0.07% |
967,492
+938,277
| +3,212% | +$301M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.